AtriCure Reports First Quarter 2013 Financial Results
05.02.2013
Highlights
Revenue of $19.4 million – up 11.2%; 11.1% constant currency
U.S. sales of $14.6 million – up 11.0%
International sales of $4.8 million – up 11.9%; 11.7% constant currency
WEST CHESTER, Ohio--(BUSINESS WIRE)--May. 2, 2013--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
the development of technologies and solutions for the treatment of
atrial fibrillation, or Afib, and systems for the exclusion of the left
atrial appendage, today announced financial results for the first
quarter of 2013.
“Our first quarter results ...AtriCure to Announce First Quarter 2013 Financial Results
04.08.2013
WEST CHESTER, Ohio--(BUSINESS WIRE)--Apr. 8, 2013--
AtriCure, Inc. (Nasdaq:ATRC), a medical device company and a leader in
the development of technologies and solutions for the treatment of
atrial fibrillation, or AF, and systems for the exclusion of the left
atrial appendage, will release its financial results for the first
quarter of 2013 on Thursday, May 2, 2013.
AtriCure will host a conference call at 4:30 p.m. Eastern Time on
Thursday, May 2, 2013 to discuss its first quarter 2013 financial
results. A live webcast of the conference call will be available online
from the investor relations page of AtriCure’s corporate...